Abiopharma

New Form 4 - CYANOTECH CORP Filed: 2025-07-31 AccNo: 0001437749-25-024124 Size: 8 KB

New Form 4 - CYANOTECH CORP Filed: 2025-07-31 AccNo: 0001437749-25-024122 Size: 9 KB

New Form 4 - CYANOTECH CORP Filed: 2025-07-31 AccNo: 0001437749-25-024120 Size: 9 KB

New Form 8-K - Elite Health Systems Inc. Filed: 2025-07-31 AccNo: 0001437749-25-024116 Size: 139 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 3 - Elite Health Systems Inc. Filed: 2025-07-31 AccNo: 0001437749-25-024115 Size: 3 KB

New Form D - Elite Health Systems Inc. Filed: 2025-07-31 AccNo: 0001437749-25-024114 Size: 9 KB

New Form 10-Q - INDIVIOR PLC Filed: 2025-07-31 AccNo: 0001625297-25-000050 Size: 7 MB

New Form 10-Q - BRISTOL MYERS SQUIBB CO Filed: 2025-07-31 AccNo: 0000014272-25-000131 Size: 12 MB

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100700 Size: 13 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100697 Size: 7 KB

New Form 3 - Pennant Group, Inc. Filed: 2025-07-31 AccNo: 0001766400-25-000098 Size: 14 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100689 Size: 13 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100675 Size: 8 KB

New Form 4 - Sage Therapeutics, Inc. Filed: 2025-07-31 AccNo: 0000950170-25-100680 Size: 7 KB